Radium-223 in an International Early Access Program (EAP): Effects of …

Radium-223 in an International Early Access Program (EAP): Effects of …

The ALSYMPCA study treated metastatic castration resistant prostate cancer patients with symptomatic bone metastases using radium-223 and best standard of care, compared with placebo and best standard of care. The results were published recently in …

(Visited 3 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.